a. Cytoplasm ![]() |
||
b. Tissue ![]() |
||
c. Neoplasm ![]() |
||
d. Oncogene ![]() |
a. Size ![]() |
||
b. Growth pattern ![]() |
||
c. Location of origin ![]() |
||
d. Appearance ![]() |
a. Invasive ![]() |
||
b. Benign ![]() |
||
c. Metastatic ![]() |
||
d. Apoptotic ![]() |
a. Studying yeast cell cultures ![]() |
||
b. Conducting experiments using mice ![]() |
||
c. Researching basic cell biology ![]() |
||
d. All of the above ![]() |
a. Describing the chemical structure of DNA ![]() |
||
b. Outlining how cancer spreads ![]() |
||
c. Identifying mutations that cause cancer ![]() |
||
d. Establishing guidelines for cancer therapy ![]() |
a. Carcinoma ![]() |
||
b. Sarcoma ![]() |
||
c. Lymphoma ![]() |
||
d. Leukemia ![]() |
a. Incurability ![]() |
||
b. Loss of growth control ![]() |
||
c. Origination in lymph ![]() |
||
d. Contagiousness ![]() |
a. He explained cancer development with autopsy findings. ![]() |
||
b. He correlated cancer progression to microscopy findings. ![]() |
||
c. He described the humoral theory. ![]() |
||
d. He thought that cancer cells came from lymph. ![]() |
a. When new cells are being formed faster than needed ![]() |
||
b. When cell death surpasses cell division (growth) ![]() |
||
c. When cell division equals cell death ![]() |
||
d. When cells no longer divide ![]() |
a. It was the first induced in lab animals. ![]() |
||
b. It was the first known to be caused by a virus. ![]() |
||
c. It developed because of the carcinogen tobacco. ![]() |
||
d. It was caused by coal tar. ![]() |
a. The theory that cancer is infectious is well established and proven true. ![]() |
||
b. The theory that cancer is infectious led cancer patients years ago to be housed in the city near other people including doctors. ![]() |
||
c. The theory that cancer is infectious was based on several members of the same household contracting breast cancer. ![]() |
||
d. The theory that cancer is infectious explains how cancer cells spread within a person. ![]() |
a. He described cancer as curable. ![]() |
||
b. He did not believe in cancer. ![]() |
||
c. He thought that cancer was incurable. ![]() |
||
d. He outlined cancer treatments. ![]() |
a. He developed anesthesia. ![]() |
||
b. He performed autopsies. ![]() |
||
c. He did radical mastectomies. ![]() |
||
d. He explained that some tumors can be removed. ![]() |
a. Celsus ![]() |
||
b. Hunter ![]() |
||
c. Hippocrates ![]() |
||
d. House ![]() |
a. Adenine ![]() |
||
b. Guanine ![]() |
||
c. Cytosine ![]() |
||
d. Thymine ![]() |
a. Thymine dimers ![]() |
||
b. Frameshift mutations ![]() |
||
c. Insertions ![]() |
||
d. Chromosome breaks ![]() |
a. Mismatch repair ![]() |
||
b. Proofreading ![]() |
||
c. Recombination ![]() |
||
d. Apoptosis ![]() |
a. Protein ![]() |
||
b. Nucleic acid ![]() |
||
c. Carbohydrate ![]() |
||
d. Lipid ![]() |
a. Nucleic acids ![]() |
||
b. Amino acids ![]() |
||
c. Monosaccharides ![]() |
||
d. Lipids ![]() |
a. Five ![]() |
||
b. Three ![]() |
||
c. Four ![]() |
||
d. Two ![]() |
a. One ![]() |
||
b. Two ![]() |
||
c. Three ![]() |
||
d. Four ![]() |
a. Create thymine dimers ![]() |
||
b. Develop base substitutions ![]() |
||
c. Have a frameshift mutation ![]() |
||
d. Exchange adenine for guanine ![]() |
a. Sucrose ![]() |
||
b. Deoxyribose ![]() |
||
c. Ribose ![]() |
||
d. Fructose ![]() |
a. To transfer phosphates ![]() |
||
b. To remove phosphates ![]() |
||
c. To bind to ligands ![]() |
||
d. To block receptor binding ![]() |
a. mRNA ![]() |
||
b. tRNA ![]() |
||
c. rRNA ![]() |
||
d. sRNA ![]() |
a. No further mutations occur. ![]() |
||
b. There will be no impact on DNA. ![]() |
||
c. DNA mutations will accumulate. ![]() |
||
d. Only repair proteins will be impacted. ![]() |
a. Cytoplasm ![]() |
||
b. Mitochondria ![]() |
||
c. Nucleus ![]() |
||
d. Cell membrane ![]() |
a. Tumor suppressors ![]() |
||
b. Oncogenes ![]() |
||
c. Proto-oncogenes ![]() |
||
d. DNA repair genes ![]() |
a. Ligand ![]() |
||
b. GTP ![]() |
||
c. Adenylyl cyclase ![]() |
||
d. cAMP ![]() |
a. Differentiation ![]() |
||
b. The production of hormones ![]() |
||
c. Proliferation of cells ![]() |
||
d. Both A and C ![]() |
a. Src ![]() |
||
b. p53 ![]() |
||
c. BRCA-1 ![]() |
||
d. Rb ![]() |
a. Ligands enter the cell and elicit their effect. ![]() |
||
b. The receptor changes conformation and directly causes DNA transcription. ![]() |
||
c. The signaling event is amplified inside the cell. ![]() |
||
d. Signal transduction cascades run indefinitely. ![]() |
a. Beta pleated sheet ![]() |
||
b. Double helix ![]() |
||
c. Single spiral ![]() |
||
d. Hexagonal plane ![]() |
a. By transferring a phosphate ![]() |
||
b. By removing a methyl group ![]() |
||
c. By binding to receptor on cell surface ![]() |
||
d. By targeting DNA for transcription ![]() |
a. G1 ![]() |
||
b. S ![]() |
||
c. G2 ![]() |
||
d. M ![]() |
a. Chromosomes line up in the center of the cell. ![]() |
||
b. DNA is replicated. ![]() |
||
c. The nuclear membrane disappears. ![]() |
||
d. Proteins pull apart the chromosomes. ![]() |
a. It is a type of eye cancer. ![]() |
||
b. It is a transcription factor. ![]() |
||
c. It is a tumor suppressor. ![]() |
||
d. All of the above ![]() |
a. Oncogenes ![]() |
||
b. Tumor suppressors ![]() |
||
c. DNA repair genes ![]() |
||
d. Accessory proteins ![]() |
a. Myc ![]() |
||
b. p53 ![]() |
||
c. Src ![]() |
||
d. Rb ![]() |
a. Myc ![]() |
||
b. p53 ![]() |
||
c. Src ![]() |
||
d. Rb ![]() |
a. G1/S ![]() |
||
b. S/G2 ![]() |
||
c. G2/M ![]() |
||
d. Metaphase/anaphase transition ![]() |
a. Cyclins ![]() |
||
b. Cyclin dependent kinases ![]() |
||
c. Tumor suppressors ![]() |
||
d. Oncogenes ![]() |
a. Inactivation of tumor suppressors ![]() |
||
b. Mutations of DNA repair genes ![]() |
||
c. Conversion of proto-oncogenes to oncogenes ![]() |
||
d. All of the above ![]() |
a. BRCA1 or BRCA2 testing is used to diagnose breast cancer. ![]() |
||
b. BRCA1 or BRCA2 testing screens for an increased risk of developing breast cancer. ![]() |
||
c. BRCA1 or BRCA2 testing is easily interpreted. ![]() |
||
d. BRCA1 or BRCA2 testing is useful for patients that have breast cancer. ![]() |
a. Myc ![]() |
||
b. Src ![]() |
||
c. p53 ![]() |
||
d. Bcl-2 ![]() |
a. G1 ![]() |
||
b. S ![]() |
||
c. G2 ![]() |
||
d. M ![]() |
a. Hyperplasia ![]() |
||
b. Dysplasia ![]() |
||
c. Anaplasia ![]() |
||
d. Carcinoma in situ ![]() |
a. Breast ![]() |
||
b. Cervix ![]() |
||
c. Liver ![]() |
||
d. Lung ![]() |
a. Dysplasia ![]() |
||
b. Carcinoma in situ ![]() |
||
c. Hyperplasia ![]() |
||
d. Anaplasia ![]() |
a. To develop a polio vaccine ![]() |
||
b. To study genetics ![]() |
||
c. To conduct numerous scientific studies ![]() |
||
d. All of the above ![]() |
a. Stimulate death receptor clustering ![]() |
||
b. Directly target caspase ![]() |
||
c. Block lipid raft fusion ![]() |
||
d. Turn off the process of apoptosis ![]() |
a. 4 months ![]() |
||
b. 3 days ![]() |
||
c. 2 weeks ![]() |
||
d. 1 hour ![]() |
a. It progresses. ![]() |
||
b. It is arrested. ![]() |
||
c. It takes twice as long. ![]() |
||
d. It requires p53. ![]() |
a. Ionizing radiation ![]() |
||
b. Depletion of growth factors and nutrients needed to survive ![]() |
||
c. Infection of the cell by a virus ![]() |
||
d. All of the above ![]() |
a. Binding of B lymphocytes to death receptors ![]() |
||
b. Signals from the mitochondria ![]() |
||
c. Granzyme ![]() |
||
d. Caspase ![]() |
a. p53 ![]() |
||
b. Myc ![]() |
||
c. IGF ![]() |
||
d. Bcl-2 ![]() |
a. Caspase ![]() |
||
b. p53 ![]() |
||
c. Telomerase ![]() |
||
d. Ras ![]() |
a. It comes before initiation. ![]() |
||
b. It does not require initiation. ![]() |
||
c. More promoters will lead to a more pronounced risk. ![]() |
||
d. Low levels of promoters will not likely cause tumor promotion. ![]() |
a. Sarcomas ![]() |
||
b. Carcinomas ![]() |
||
c. Blastomas ![]() |
||
d. All of the above ![]() |
a. Telomeres are replaced. ![]() |
||
b. Telomeres are removed. ![]() |
||
c. Telomeres lengthen. ![]() |
||
d. Telomeres shorten. ![]() |
a. Necrosis ![]() |
||
b. Apoptosis ![]() |
||
c. Replication ![]() |
||
d. Mutation ![]() |
a. Stimulate growth factors. ![]() |
||
b. Induce angiogenesis. ![]() |
||
c. Build the basement membrane. ![]() |
||
d. Destroy extracellular matrix (ECM). ![]() |
a. Oncogenesis ![]() |
||
b. Metastasis ![]() |
||
c. Angiogenesis ![]() |
||
d. Anaplasia ![]() |
a. Adrenal ![]() |
||
b. Lung ![]() |
||
c. Liver ![]() |
||
d. Renal ![]() |
a. Heart ![]() |
||
b. Lungs ![]() |
||
c. Liver ![]() |
||
d. Cervix ![]() |
a. Adhesion molecules ![]() |
||
b. The absence of growth factors ![]() |
||
c. The blood vessel size supplying that tissue ![]() |
||
d. Platelets ![]() |
a. Breast ![]() |
||
b. Lung ![]() |
||
c. Blood ![]() |
||
d. Colon ![]() |
a. VEGF ![]() |
||
b. bFGF ![]() |
||
c. Endostatin ![]() |
||
d. p53 ![]() |
a. In the blood ![]() |
||
b. In the lymphatic system ![]() |
||
c. Through body walls ![]() |
||
d. Via the gastrointestinal tract ![]() |
a. VEGF ![]() |
||
b. p53 ![]() |
||
c. Ras ![]() |
||
d. BRCA1 ![]() |
a. Everyone has slightly different lymphatic networks. ![]() |
||
b. More cells are found in lymph than in blood, making it hard to spot cancer cells. ![]() |
||
c. Tumor cells do not interact with the lymphatic vessels. ![]() |
||
d. Lymph nodes hide cancer cells, making it difficult to detect them there. ![]() |
a. Angiogenesis ![]() |
||
b. Oncoprogression ![]() |
||
c. Hitching ![]() |
||
d. Metastasis ![]() |
a. An initiator ![]() |
||
b. An inducer ![]() |
||
c. A promoter ![]() |
||
d. Both A and C ![]() |
a. Proliferation ![]() |
||
b. Biotransformation ![]() |
||
c. Promotion ![]() |
||
d. Induction ![]() |
a. In an animal model ![]() |
||
b. In a single concentration ![]() |
||
c. In isolation ![]() |
||
d. At high rates of speed ![]() |
a. Cervical ![]() |
||
b. Endometrial ![]() |
||
c. Breast ![]() |
||
d. Bladder ![]() |
a. Genetics ![]() |
||
b. Environmental factors ![]() |
||
c. Nutritional status ![]() |
||
d. Older age ![]() |
a. 1 ![]() |
||
b. 2A ![]() |
||
c. 2B ![]() |
||
d. 3 ![]() |
a. Time of exposure ![]() |
||
b. Potency ![]() |
||
c. Dose-response ![]() |
||
d. All of the above ![]() |
a. Literacy ![]() |
||
b. Race ![]() |
||
c. Gender ![]() |
||
d. Income ![]() |
a. UV radiation ![]() |
||
b. Oxygen free radicals ![]() |
||
c. Genetics ![]() |
||
d. Viruses ![]() |
a. Smoking ![]() |
||
b. Asbestos ![]() |
||
c. Radon ![]() |
||
d. Arsenic ![]() |
a. Aflatoxins ![]() |
||
b. Benzene ![]() |
||
c. Hepatitis B and C viruses ![]() |
||
d. Alcohol ![]() |
a. Breast ![]() |
||
b. Lung ![]() |
||
c. Colorectal ![]() |
||
d. Prostate ![]() |
a. Breast cancer ![]() |
||
b. Colon cancer ![]() |
||
c. Cervical cancer ![]() |
||
d. Lung cancer ![]() |
a. 35 ![]() |
||
b. 45 ![]() |
||
c. 40 ![]() |
||
d. 50 ![]() |
a. No later than 21 ![]() |
||
b. 30 ![]() |
||
c. Before 21 if sexually active ![]() |
||
d. Both A and C ![]() |
a. Microarray ![]() |
||
b. Mammogram ![]() |
||
c. Biopsy ![]() |
||
d. Oncogram ![]() |
a. Metastasis ![]() |
||
b. Loss of cell growth ![]() |
||
c. Patient’s chance of survival ![]() |
||
d. Risk for secondary infection ![]() |
a. UV radiation ![]() |
||
b. Tobacco smoking ![]() |
||
c. Radioisotopes ![]() |
||
d. Genetics ![]() |
a. Sarcoma ![]() |
||
b. Blastoma ![]() |
||
c. Carcinoma ![]() |
||
d. Melanoma ![]() |
a. Breast cancer ![]() |
||
b. Cervical cancer ![]() |
||
c. Prostate cancer ![]() |
||
d. Colon cancer ![]() |
a. Eat a high fiber diet ![]() |
||
b. Exercise daily ![]() |
||
c. Avoid tobacco ![]() |
||
d. Have an annual check-up ![]() |
a. Environmental exposure ![]() |
||
b. Genetic predisposition ![]() |
||
c. Dietary intake ![]() |
||
d. Medical status ![]() |
a. Tobacco ![]() |
||
b. Poor diet ![]() |
||
c. Alcohol ![]() |
||
d. Both A and C ![]() |
a. Pap ![]() |
||
b. Mammogram ![]() |
||
c. PSA ![]() |
||
d. Fecal occult blood ![]() |
a. Pap ![]() |
||
b. Mammogram ![]() |
||
c. PSA ![]() |
||
d. Fecal occult blood ![]() |
a. Screening methods provide a definitive diagnosis. ![]() |
||
b. Screening methods are used to detect cancer in patients without symptoms. ![]() |
||
c. Screening methods should only be used if a patient has cancer symptoms. ![]() |
||
d. Screening methods have not made a significant impact on cancer prognosis. ![]() |
a. They mark cancer cells to be killed. ![]() |
||
b. They block important receptors on cancer cells. ![]() |
||
c. They carry toxic substances to the cancer cells. ![]() |
||
d. Both A and C ![]() |
a. Radiation ![]() |
||
b. Immunotherapy ![]() |
||
c. Chemotherapy ![]() |
||
d. Both A and C ![]() |
a. Methotrexate ![]() |
||
b. Doxil ![]() |
||
c. Mustard gas ![]() |
||
d. Avastin ![]() |
a. Chronic myelogenous leukemia ![]() |
||
b. Lymphoma ![]() |
||
c. Kaposi’s Sarcoma ![]() |
||
d. Acute colon cancer ![]() |
a. Cells lining the gastrointestinal track ![]() |
||
b. Cancer cells ![]() |
||
c. Bone marrow cells ![]() |
||
d. Skeletal muscle cells ![]() |
a. Inducing apoptosis ![]() |
||
b. Cell division ![]() |
||
c. Cancer cell proliferation ![]() |
||
d. Signaling ![]() |
a. Spindle promoter ![]() |
||
b. Antimetabolite ![]() |
||
c. Genotoxic agent ![]() |
||
d. Purine and pyrimidine antagonists ![]() |
a. Kinase inhibitor ![]() |
||
b. Angiogenesis inhibitor ![]() |
||
c. Antimetabolites ![]() |
||
d. Antisense oligonucleotides ![]() |
a. It is toxic to normal cells. ![]() |
||
b. The same siRNA cannot be used a second time if cancer returns. ![]() |
||
c. It is impossible to get siRNA into cells. ![]() |
||
d. siRNA stimulates an immune response. ![]() |
a. Lentivirus ![]() |
||
b. Adenovirus ![]() |
||
c. Herpes simplex virus ![]() |
||
d. Epstein Barr Virus ![]() |
a. To repair damaged tissues ![]() |
||
b. For long term maintenance ![]() |
||
c. To divide into tissue that will form organs ![]() |
||
d. To complete body tissues ![]() |
a. Esophagus ![]() |
||
b. Lung ![]() |
||
c. Prostate ![]() |
||
d. Colon ![]() |